Related Experiment Video
Updated: Jan 22, 2026

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
Published on: February 28, 2019
MERTK Acts as a Costimulatory Receptor on Human CD8+ T Cells
Marlies J W Peeters1, Donata Dulkeviciute2, Arianna Draghi2
1Department of Hematology, Center for Cancer Immune Therapy, University Hospital Herlev, Copenhagen, Denmark. per.thor.straten@regionh.dk marlies.peeters@regionh.dk.
Abstract:
The TAM family of receptor tyrosine kinases (TYRO3, AXL, and MERTK) is known to be expressed on antigen-presenting cells and function as oncogenic drivers and as inhibitors of inflammatory responses. Both human and mouse CD8+ T cells are thought to be negative for TAM receptor expression. In this study, we show that T-cell receptor (TCR)-activated human primary CD8+ T cells expressed MERTK and the ligand PROS1 from day 2 postactivation. PROS1-mediated MERTK signaling served as a late costimulatory signal, increasing proliferation and secretion of effector and memory-associated cytokines. Knockdown and inhibition studies confirmed that this costimulatory effect was mediated through MERTK. Transcriptomic and metabolic analyses of PROS1-blocked CD8+ T cells demonstrated a role of the PROS1-MERTK axis in differentiation of memory CD8+ T cells. Finally, using tumor-infiltrating lymphocytes (TIL) from melanoma patients, we show that MERTK signaling on T cells improved TIL expansion and TIL-mediated autologous cancer cell killing. We conclude that MERTK serves as a late costimulatory signal for CD8+ T cells. Identification of this costimulatory function of MERTK on human CD8+ T cells suggests caution in the development of MERTK inhibitors for hematologic or solid cancer treatment.
Insights
Activated CD8+ T cells express MERTK, a receptor tyrosine kinase, which enhances their proliferation and cytokine secretion. This MERTK signaling also boosts tumor-infiltrating lymphocytes in melanoma, suggesting caution with MERTK inhibitors.
Area of Science:
- Immunology
- Molecular Biology
- Cancer Research
Background:
- TAM receptor tyrosine kinases (TYRO3, AXL, MERTK) are involved in immune regulation and cancer.
- CD8+ T cells were previously thought to lack TAM receptor expression.
Purpose of the Study:
- To investigate the expression and function of TAM receptors, specifically MERTK, in activated human CD8+ T cells.
- To determine the role of MERTK signaling in T cell responses and anti-tumor immunity.
Main Methods:
- T-cell receptor activation of primary human CD8+ T cells.
- Analysis of MERTK and PROS1 expression post-activation.
- Knockdown and inhibition studies to assess MERTK function.
- Transcriptomic and metabolic analyses.
- Studies using tumor-infiltrating lymphocytes (TIL) from melanoma patients.
Main Results:
- TCR-activated human CD8+ T cells express MERTK and its ligand PROS1.
- PROS1-mediated MERTK signaling acts as a late costimulatory signal, enhancing T cell proliferation and cytokine production.
- MERTK signaling is crucial for memory CD8+ T cell differentiation.
- MERTK signaling on T cells improves TIL expansion and cancer cell killing in melanoma.
Conclusions:
- MERTK functions as a late costimulatory signal for human CD8+ T cells.
- The PROS1-MERTK axis plays a significant role in T cell immunity and anti-tumor responses.
- Targeting MERTK warrants caution due to its beneficial role in T cell function and anti-cancer immunity.
Related Concept Videos
Forces Acting on Chromosomes
Microtubules and motor proteins exert two types of forces on...
Types of Receptors: Cell Surface Receptors
Internal Receptors
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Drugs Acting on Autonomic Ganglia: Blockers

